618 related articles for article (PubMed ID: 18043104)
21. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
22. Late results of the surgical treatment of 125 patients with short-segment Barrett esophagus.
Csendes A; Braghetto I; Burdiles P; Smok G; Henríquez A; Burgos AM
Arch Surg; 2009 Oct; 144(10):921-7. PubMed ID: 19841359
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery.
McCarthy M; Wilkinson ML
Gastrointest Endosc; 1999 Jan; 49(1):129-30. PubMed ID: 10048955
[No Abstract] [Full Text] [Related]
24. High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation.
Mörk H; Al-Taie O; Berlin F; Kraus MR; Scheurlen M
Scand J Gastroenterol; 2007 Jan; 42(1):23-7. PubMed ID: 17190758
[TBL] [Abstract][Full Text] [Related]
25. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma.
Van Laethem JL; Jagodzinski R; Peny MO; Cremer M; Devière J
Endoscopy; 2001 Mar; 33(3):257-61. PubMed ID: 11293760
[TBL] [Abstract][Full Text] [Related]
26. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
27. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).
Sharma VK; Kim HJ; Das A; Dean P; DePetris G; Fleischer DE
Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074
[TBL] [Abstract][Full Text] [Related]
28. Course of erosive gastroesophageal reflux disease (ERD)--a prospective examination under therapeutic daily life conditions with a mean follow-up of 6.5 years.
Hartmann D; Kudis V; Jakobs R; Riemann JF; Schilling D
Z Gastroenterol; 2006 Oct; 44(10):1039-42. PubMed ID: 17063432
[TBL] [Abstract][Full Text] [Related]
29. The effects of laparoscopic Nissen fundoplication on Barrett's esophagus: long-term results.
Simonka Z; Paszt A; Abrahám S; Pieler J; Tajti J; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Rárosi F; Lázár G
Scand J Gastroenterol; 2012 Jan; 47(1):13-21. PubMed ID: 22150083
[TBL] [Abstract][Full Text] [Related]
30. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis.
McDougall NI; Johnston BT; Collins JS; McFarland RJ; Love AH
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1161-7. PubMed ID: 9471021
[TBL] [Abstract][Full Text] [Related]
31. Prospective evaluation of a new high-power argon plasma coagulation system (hp-APC) in therapeutic gastrointestinal endoscopy.
Manner H; May A; Rabenstein T; Pech O; Nachbar L; Enderle MD; Gossner L; Ell C
Scand J Gastroenterol; 2007 Mar; 42(3):397-405. PubMed ID: 17354121
[TBL] [Abstract][Full Text] [Related]
32. Barrett's esophagus without esophageal stricture does not increase the rate of failure of Nissen fundoplication.
Parrilla P; Martínez de Haro LF; Ortiz A; Munitiz V; Serrano A; Torres G
Ann Surg; 2003 Apr; 237(4):488-93. PubMed ID: 12677144
[TBL] [Abstract][Full Text] [Related]
33. Two-year subjective, objective, quality of life, and endoscopic follow-up after laparoscopic Nissen-Rossetti in patients with columnar-lined esophagus.
Marano S; Mattacchione S; Luongo B; Mingarelli V; Campagna G; Tosato F
Surg Laparosc Endosc Percutan Tech; 2013 Jun; 23(3):292-8. PubMed ID: 23751995
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Barrett's esophagus by endoscopic argon plasma coagulation.
Dumoulin FL; Terjung B; Neubrand M; Scheurlen C; Fischer HP; Sauerbruch T
Endoscopy; 1997 Oct; 29(8):751-3. PubMed ID: 9427496
[TBL] [Abstract][Full Text] [Related]
35. Transthoracic Heller myotomy for esophageal achalasia: analysis of long-term results.
Gaissert HA; Lin N; Wain JC; Fankhauser G; Wright CD; Mathisen DJ
Ann Thorac Surg; 2006 Jun; 81(6):2044-9. PubMed ID: 16731127
[TBL] [Abstract][Full Text] [Related]
36. Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication.
Bright T; Watson DI; Tam W; Game PA; Ackroyd R; Devitt PG; Schoeman MN
Dig Dis Sci; 2009 Dec; 54(12):2606-11. PubMed ID: 19101798
[TBL] [Abstract][Full Text] [Related]
37. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection.
Peters F; Kara M; Rosmolen W; Aalders M; Ten Kate F; Krishnadath K; van Lanschot J; Fockens P; Bergman J
Endoscopy; 2005 May; 37(5):418-24. PubMed ID: 15844019
[TBL] [Abstract][Full Text] [Related]
38. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
Kelty CJ; Ackroyd R; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1289-96. PubMed ID: 15606390
[TBL] [Abstract][Full Text] [Related]
39. Argon plasma coagulation of cervical heterotopic gastric mucosa as an alternative treatment for globus sensations.
Bajbouj M; Becker V; Eckel F; Miehlke S; Pech O; Prinz C; Schmid RM; Meining A
Gastroenterology; 2009 Aug; 137(2):440-4. PubMed ID: 19410576
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up.
Fleischer DE; Overholt BF; Sharma VK; Reymunde A; Kimmey MB; Chuttani R; Chang KJ; Lightdale CJ; Santiago N; Pleskow DK; Dean PJ; Wang KK
Gastrointest Endosc; 2008 Nov; 68(5):867-76. PubMed ID: 18561930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
